4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-030723
Director sold 273 shares at $46.06 ($12,574)
- Director acquired 545 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gallagher Carol Giltner Director | 2018-05-15 | Option exercise | +545 | 111,465 | D | ||
| Gallagher Carol Giltner Director | 2018-05-16 | Sale | −273 | $46.06 | $12,574 | 111,192 | D |
| Derivatives | |||||||
| Gallagher Carol Giltner Director | 2018-05-15 | Option exercise · Restricted Stock Units | −545 | 0 | D | ||
| Open-market sales · 273 sh · avg $46.06 · $12,574 | |||||||
Loading xslF345X03/doc4.xml…